Clinical Trial Update: A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring Endostar with chemotherapy and immunotherapy in lung squamous cell carcinoma is reported but current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Xuzhou Medical University | Conditions: Lung Squamous Cell Carcinoma | Phase 4 | Status: UNKNOWN